Cell culture in immune cell therapies: do more with less

In this expert roundtable, David McCall, Senior Editor, BioInsights, speaks to (pictured left to right) Anastasiya Smith, Senior Director R&D, CellReady, Josh Ludwig, Global Director, Commercial Operations, ScaleReady, & David Hermanson, Senior Manager of R&D Applications, Cell and Gene Therapy, Bio-Techne. The panel discusses the importance of cytokine levels and the effects on phenotype, in addition to how to reduce complexity and cost from early research through commercial scale-up in a closed system.

Please enter your email to access content Read now